Global investment firm KKR has agreed to acquire a minority stake in Malaysian healthcare provider Avisena Healthcare.
The investment will allow Avisena to expand multi-specialty offerings at its flagship hospitals in Shah Alam and develop greenfield hospitals within the Klang Valley.
The deal is subject to the satisfaction of customary closing conditions. Financial terms of the transaction were not disclosed.
Founded in 1996, Avisena has established a leading healthcare presence in Shah Alam and the wider Klang Valley, Malaysia, where it operates Avisena Specialist Hospital and Avisena Specialist Hospital 2. Malaysia’s private healthcare market is experiencing rising demand, with capacity growth lagging demand in key urban areas.
“Avisena has built a differentiated healthcare platform serving the community for over 30 years, anchored by a strong commitment to delivering quality, accessible patient care,” says KKR managing director SJ Lim. “We look forward to contributing towards building the business and working together with the Avisena team.”
Since 2004, KKR has invested more than US$20 billion across the global healthcare ecosystem, working with healthcare businesses to support investment in clinical capabilities, technology and infrastructure and to expand access to high-quality care.
Across Asia-Pacific, its healthcare portfolio includes Medical Saigon Group in Vietnam and Metro Pacific Hospital Holdings in the Philippines, as well as investments in healthcare businesses in India, Japan and China.
In Malaysia, KKR's investments have included OMS Group, Weststar Aviation, and Taylor’s Schools, reflecting its approach of being an engaged, value-added strategic partner alongside founders and management teams.
